Kastrinos, F., Kupfer, S. S. & Gupta, S. Colorectal cancer risk assessment and precision approaches to screening: brave new world or worlds apart? Gastroenterology 164, 812–827 (2023).

Article  PubMed  Google Scholar 

Ten Haaf, K., van der Aalst, C. M., de Koning, H. J., Kaaks, R. & Tammemägi, M. C. Personalising lung cancer screening: an overview of risk-stratification opportunities and challenges. Int. J. Cancer 149, 250–263 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Pinsky, P. F. & Parnes, H. Screening for prostate cancer. N. Engl. J. Med. 388, 1405–1414 (2023).

Article  PubMed  Google Scholar 

Potnis, K. C., Ross, J. S., Aneja, S., Gross, C. P. & Richman, I. B. Artificial intelligence in breast cancer screening: evaluation of FDA device regulation and future recommendations. JAMA Intern. Med. 182, 1306–1312 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151–171 (2019).

Article  PubMed  Google Scholar 

Huang, D. Q. et al. Global epidemiology of cirrhosis – aetiology, trends and predictions. Nat. Rev. Gastroenterol. Hepatol. 20, 388–398 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Ginès, P. et al. Liver cirrhosis. Lancet 398, 1359–1376 (2021).

Article  PubMed  Google Scholar 

Pellicoro, A., Ramachandran, P., Iredale, J. P. & Fallowfield, J. A. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat. Rev. Immunol. 14, 181–194 (2014).

Article  CAS  PubMed  Google Scholar 

Berzigotti, A. et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. J. Hepatol. 75, 659–689 (2021).

Article  Google Scholar 

Collaborators, G. C. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5, 245–266 (2020).

Article  Google Scholar 

Vos, T. et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020).

Article  Google Scholar 

Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79, 516–537 (2023).

Article  PubMed  Google Scholar 

Jepsen, P. & Younossi, Z. M. The global burden of cirrhosis: a review of disability-adjusted life-years lost and unmet needs. J. Hepatol. 75, S3–S13 (2021).

Article  PubMed  Google Scholar 

Ma, C. et al. Trends in the economic burden of chronic liver diseases and cirrhosis in the United States: 1996-2016. Am. J. Gastroenterol. 116, 2060–2067 (2021).

Article  PubMed  Google Scholar 

Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 78, 1966–1986 (2023).

Article  Google Scholar 

Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851–861 (2022).

Article  PubMed  Google Scholar 

Allen, A. M. et al. Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design. J. Hepatol. 77, 1237–1245 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karlsen, T. H. et al. The EASL Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 399, 61–116 (2022).

Article  PubMed  Google Scholar 

de Koning, H. J. et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N. Engl. J. Med. 382, 503–513 (2020).

Article  PubMed  Google Scholar 

Bretthauer, M. et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N. Engl. J. Med. 387, 1547–1556 (2022).

Article  PubMed  Google Scholar 

World Health Organization. Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimze harm. WHO https://www.who.int/europe/publications/i/item/9789289054782 (2020).

Wilson, J. M. G. & Jungner, G. Principles and practice of screening for disease. Public Health Papers No. 34 (WHO, 1968).

Shieh, Y. et al. Population-based screening for cancer: hope and hype. Nat. Rev. Clin. Oncol. 13, 550–565 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lindvig, K. P. et al. Diagnostic accuracy of routine liver function tests to identify patients with significant and advanced alcohol-related liver fibrosis. Scand. J. Gastroenterol. 56, 1088–1095 (2021).

Article  CAS  PubMed  Google Scholar 

Borzio, M. et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108, 812–817 (1995).

Article  CAS  PubMed  Google Scholar 

D’Ambrosio, R. et al. Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR. J. Hepatol. 76, 302–310 (2022).

Article  PubMed  Google Scholar 

D’Amico, G. et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment. Pharmacol. Ther. 39, 1180–1193 (2014).

Article  PubMed  Google Scholar 

Jepsen, P., Ott, P., Andersen, P. K., Sorensen, H. T. & Vilstrup, H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 51, 1675–1682 (2010).

Article  PubMed  Google Scholar 

Carol, M. et al. Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life. PLoS ONE 17, e0265153 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchesini, G. et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 120, 170–178 (2001).

Article  CAS  PubMed  Google Scholar 

Askgaard, G. et al. Socioeconomic inequalities in the incidence of alcohol-related liver disease: a nationwide Danish study. Lancet Reg. Health Eur. 8, 100172 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Ginès, P. et al. Population screening for liver fibrosis: towards early diagnosis and intervention for chronic liver diseases. Hepatology 75, 219–228 (2022).

Article  PubMed  Google Scholar 

Rasmussen, D. N. et al. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease. J. Hepatol. 75, 1017–1025 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boursier, J. et al. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events. J. Hepatol. 76, 1013–1020 (2022).

Article  CAS  PubMed  Google Scholar 

Sanyal, A. J. et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N. Engl. J. Med. 385, 1559–1569 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dobrow, M. J., Hagens, V., Chafe, R., Sullivan, T. & Rabeneck, L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ 190, E422–E429 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Anstee, Q. M., Castera, L. & Loomba, R. Impact of non-invasive biomarkers on hepatology practice: past, present and future. J. Hepatol. 76, 1362–1378 (2022).

Article  CAS  PubMed  Google Scholar 

Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43, 1317–1325 (2006).

Article  CAS  PubMed  Google Scholar 

Castéra, L. et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128, 343–350 (2005).

Article  PubMed  Google Scholar 

Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846–854 (2007).

Article  CAS  PubMed  Google Scholar 

Labenz, C. et al. Structured early detection of asymptomatic liver cirrhosis: results of the population-based liver screening program SEAL. J. Hepatol. 77, 695–701 (2022).

Article  PubMed  Google Scholar 

Innes, H. et al. Performance of routine risk scores for predicting cirrhosis-related morbidity in the community. J. Hepatol. 77, 365–376 (2022).

Article